KR102413041B1 - 기능성 세포 상태의 확인 - Google Patents

기능성 세포 상태의 확인 Download PDF

Info

Publication number
KR102413041B1
KR102413041B1 KR1020167022058A KR20167022058A KR102413041B1 KR 102413041 B1 KR102413041 B1 KR 102413041B1 KR 1020167022058 A KR1020167022058 A KR 1020167022058A KR 20167022058 A KR20167022058 A KR 20167022058A KR 102413041 B1 KR102413041 B1 KR 102413041B1
Authority
KR
South Korea
Prior art keywords
cell
cells
tensor
delete delete
response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167022058A
Other languages
English (en)
Korean (ko)
Other versions
KR20160110444A (ko
Inventor
바르트로미에지 라즈와
티. 빈센트 샨키
Original Assignee
아세다사이언시즈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아세다사이언시즈 아게 filed Critical 아세다사이언시즈 아게
Publication of KR20160110444A publication Critical patent/KR20160110444A/ko
Application granted granted Critical
Publication of KR102413041B1 publication Critical patent/KR102413041B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/40—Searching chemical structures or physicochemical data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C99/00—Subject matter not provided for in other groups of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Theoretical Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Computing Systems (AREA)
  • Physiology (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
KR1020167022058A 2014-01-14 2015-01-14 기능성 세포 상태의 확인 Active KR102413041B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927247P 2014-01-14 2014-01-14
US61/927,247 2014-01-14
PCT/US2015/011441 WO2015109003A1 (en) 2014-01-14 2015-01-14 Identification of functional cell states

Publications (2)

Publication Number Publication Date
KR20160110444A KR20160110444A (ko) 2016-09-21
KR102413041B1 true KR102413041B1 (ko) 2022-06-23

Family

ID=52440877

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167022058A Active KR102413041B1 (ko) 2014-01-14 2015-01-14 기능성 세포 상태의 확인

Country Status (11)

Country Link
US (3) US11137388B2 (enExample)
EP (1) EP3094974B1 (enExample)
JP (1) JP6606100B2 (enExample)
KR (1) KR102413041B1 (enExample)
AU (2) AU2015206520B2 (enExample)
CA (1) CA2972960C (enExample)
DK (1) DK3094974T3 (enExample)
ES (1) ES2728119T3 (enExample)
IL (1) IL246734B (enExample)
SG (1) SG11201705495XA (enExample)
WO (1) WO2015109003A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states
CA2977481C (en) 2015-02-24 2021-02-02 The University Of Tokyo Dynamic high-speed high-sensitivity imaging device and imaging method
EP3372985B1 (en) 2015-10-28 2025-06-25 The University Of Tokyo Analysis device
US10824693B2 (en) 2015-12-10 2020-11-03 Reservoir Labs, Inc. Systems and methods for selective expansive recursive tensor analysis
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US12300357B2 (en) 2016-12-14 2025-05-13 FlowJo, LLC Applied computer technology for management, synthesis, visualization, and exploration of parameters in large multi-parameter data sets
US11573182B2 (en) 2017-05-25 2023-02-07 FlowJo, LLC Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets
WO2019241443A1 (en) 2018-06-13 2019-12-19 Thinkcyte Inc. Methods and systems for cytometry
US11972858B2 (en) 2019-05-14 2024-04-30 University Of Pittsburgh-Of The Commonwealth System Of Higher Education System and method for characterizing cellular phenotypic diversity from multi-parameter cellular, and sub-cellular imaging data
EP4083603A4 (en) 2019-12-27 2024-04-03 ThinkCyte, Inc. FLOW CYTOMETER PERFORMANCE EVALUATION METHODS AND STANDARD PARTICLE SUSPENSION
WO2021200960A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 観察装置
WO2021200911A1 (ja) 2020-04-01 2021-10-07 シンクサイト株式会社 フローサイトメーター
WO2022026532A1 (en) * 2020-07-30 2022-02-03 Allen Institute Systems, devices, and methods for compound screening using predictive tagging
US20240337647A1 (en) 2021-07-26 2024-10-10 Asedasciences Ag Improved methods for identification of functional cell states
WO2023056481A1 (en) * 2021-10-01 2023-04-06 CAP Diagnostics, LLC, dba Pathnostics Automated methods and systems for rapid identification of target particles
US12105081B2 (en) * 2021-10-20 2024-10-01 Travera, Inc. Treatment response assessment using normalized single cell measurements
IL322273A (en) 2023-01-23 2025-09-01 Asedasciences Ag Improved human-computer interaction systems

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157269A1 (en) 2000-03-06 2004-08-12 Berg Ellen L. Function homology screening
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5544650A (en) * 1988-04-08 1996-08-13 Neuromedical Systems, Inc. Automated specimen classification system and method
AU6024294A (en) 1993-01-08 1994-08-15 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
CA2196496A1 (en) 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US20050221280A1 (en) 1998-02-02 2005-10-06 Odyssey Thera, Inc. Protein-protein interactions for pharmacological profiling
US7166424B2 (en) 1998-02-02 2007-01-23 Odyssey Thera Inc. Fragments of fluorescent proteins for protein fragment complementation assays
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6998249B1 (en) 1999-09-27 2006-02-14 Pharmacia & Upjohn Company Toxicity screening method
EP1290428A1 (en) 2000-06-02 2003-03-12 Medicometrics APS Method and system for classifying a biological sample
US7146349B2 (en) * 2000-11-06 2006-12-05 International Business Machines Corporation Network for describing multimedia information
WO2004094609A2 (en) 2003-04-23 2004-11-04 Bioseek, Inc. Methods for characterizing signaling pathways and compounds that interact therewith
WO2008134593A1 (en) * 2007-04-25 2008-11-06 President And Fellows Of Harvard College Molecular circuits
WO2009146036A2 (en) * 2008-04-01 2009-12-03 Purdue Research Foundation Quantification of differences between measured values and statistical validation based on the differences
US20130226469A1 (en) 2008-04-01 2013-08-29 Purdue Research Foundation Gate-free flow cytometry data analysis
EP3094974B1 (en) * 2014-01-14 2019-02-27 Asedasciences AG Identification of functional cell states

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040157269A1 (en) 2000-03-06 2004-08-12 Berg Ellen L. Function homology screening
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
L. A. Sklar 외, "Flow Cytometry for Drug Discovery, Receptor Pharmacology and High Throughput Screening", Curr. Opin. Pharmacol., 7(5):527-534. (2007.10.)*
M. H. Woehrmann 외, "Large-scale cytological profiling for functional analysis of bioactive compounds", Mol. BioSyst., 9:2604-2617. (2013.)*
M. M. Hammer 외, "WebFlow: A Software Package for High-Throughput Analysis of Flow Cytometry Data", Assay and Drug Development Technologies, 7(1):44-55. (2009.02.01.)
Y. Feng 외, "Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds", Nature Reviews Drug Discovery, 8(7):567-578. (2009.07.01.)

Also Published As

Publication number Publication date
US11137388B2 (en) 2021-10-05
DK3094974T3 (da) 2019-05-27
JP6606100B2 (ja) 2019-11-13
AU2021204419A1 (en) 2021-07-22
US11867690B2 (en) 2024-01-09
JP2017505140A (ja) 2017-02-16
US20160370350A1 (en) 2016-12-22
ES2728119T3 (es) 2019-10-22
KR20160110444A (ko) 2016-09-21
CA2972960A1 (en) 2015-07-23
US20210364499A1 (en) 2021-11-25
AU2015206520B2 (en) 2021-07-22
SG11201705495XA (en) 2017-08-30
EP3094974B1 (en) 2019-02-27
EP3094974A1 (en) 2016-11-23
AU2015206520A1 (en) 2016-07-14
IL246734A0 (en) 2016-08-31
WO2015109003A1 (en) 2015-07-23
HK1231553A1 (en) 2017-12-22
US20150198584A1 (en) 2015-07-16
IL246734B (en) 2019-06-30
CA2972960C (en) 2022-01-11

Similar Documents

Publication Publication Date Title
KR102413041B1 (ko) 기능성 세포 상태의 확인
Gadalla et al. Validation of CyTOF against flow cytometry for immunological studies and monitoring of human cancer clinical trials
O'Neill et al. Flow cytometry bioinformatics
Leelatian et al. Characterizing phenotypes and signaling networks of single human cells by mass cytometry
Lee et al. Application of artificial intelligence to in vitro tumor modeling and characterization of the tumor microenvironment
CN103562920A (zh) 混合模型密度设门中的邻域阈值选取
Tsiper et al. Differential mitochondrial toxicity screening and multi-parametric data analysis
EP3377896A1 (en) High-throughput imaging-based methods for predicting cell-type-specific toxicity of xenobiotics with diverse chemical structures
US20240337647A1 (en) Improved methods for identification of functional cell states
Persson et al. Advances in predictive toxicology for discovery safety through high content screening
JP2013529891A (ja) 無標識オンターゲット薬理学方法
US20050282208A1 (en) Cellular phenotype
Veschini et al. High-content imaging to phenotype human primary and ipsc-derived cells
Mancia et al. Quantitative methods to characterize morphological properties of cell lines
HK1231553B (en) Identification of functional cell states
Frey et al. Single-Cell Morphological Profiling Reveals Insights into Programmed Cell Death
US20230137843A1 (en) Holographic video microscopy cell viability assay
US20070082327A1 (en) Cellular phenotype
US20050014131A1 (en) Methods and apparatus for investigating side effects
Wong et al. Enhanced Precision in Cell Culture Analytics: Leveraging Artificial Intelligence for Unbiased and Non-Destructive Assessment of Cell Growth and Viability
Pushpan et al. An Introduction to Multiparametric Flow Cytometry in Translational Research
WO2025170878A1 (en) Methods for high-throughput drug screens at clonal resolution
Strassner et al. Relationships between metabolism of cryopreserved equine sperm determined by the Seahorse Analyzer and sperm characteristics measured by flow cytometry and computer assisted analysis of motility
Aghaeepour et al. Flow cytometry bioinformatics
Mattingly Mathematical Models for Understanding Dynamic Cellular Systems

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160811

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20190930

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210625

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20220406

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220621

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220621

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20250611

Start annual number: 4

End annual number: 4